SUMMARY
Brokerage Radar: Credit Suisse believes that Metropolis Healthcare's stock is expensive despite the correction while Morgan Stanley sees Sobha well-positioned to benefit from a strong residential upcycle. Here are top brokerage calls for the day:
1 / 4
Nomura on Voltas | Valuations are factoring in a strong summer season, said Nomura while maintaining its 'neutral' rating on shares of Voltas.
2 / 4Credit Suisse on Metropolis Health | The downside risk is still high and the stock is expensive despite the correction, according to Credit Suisse. The brokerage firm has retained its 'underperform' rating on the stock.
3 / 4Morgan Stanley on Sobha | Sobha is well-positioned to benefit from a strong residential upcycle, as per Morgan Stanley. Further, supply-side consolidation will benefit large branded players, the brokerage firm added.
4 / 4Morgan Stanley on Power Grid Corporation of India | The brokerage firm says near-term earnings visibility for Power Grid is reasonable. Additionally, asset monetisation should lead to increased dividend payout, Morgan Stanley added.
